Top

BMC Infectious Diseases

Published in:

Open Access 01-12-2017 | Research article

Direct and indirect effects of influenza vaccination

Authors: Martin Eichner, Markus Schwehm, Linda Eichner, Laetitia Gerlier

Published in: BMC Infectious Diseases | Issue 1/2017

Abstract

Background

After vaccination, vaccinees acquire some protection against infection and/or disease. Vaccination, therefore, reduces the number of infections in the population. Due to this herd protection, not everybody needs to be vaccinated to prevent infections from spreading.

Methods

We quantify direct and indirect effects of influenza vaccination examining the standard Susceptible-Infected-Recovered (SIR) and Susceptible-Infected-Recovered-Susceptible (SIRS) model as well as simulation results of a sophisticated simulation tool which allows for seasonal transmission of four influenza strains in a population with realistic demography and age-dependent contact patterns.

Results

As shown analytically for the simple SIR and SIRS transmission models, indirect vaccination effects are bigger than direct ones if the effective reproduction number of disease transmission is close to the critical value of 1. Simulation results for 20–60% vaccination with live influenza vaccine of 2–17 year old children in Germany, averaged over 10 years (2017–26), confirm this result: four to seven times as many influenza cases are prevented among non-vaccinated individuals as among vaccinees. For complications like death due to influenza which occur much more frequently in the unvaccinated elderly than in the vaccination target group of children, indirect benefits can surpass direct ones by a factor of 20 or even more than 30.

Conclusions

The true effect of vaccination can be much bigger than what would be expected by only looking at vaccination coverage and vaccine efficacy.

Available only for authorised users

Piedra PA, Gaglani MJ, Kozinetz CA, Herschler G, Riggs M, Griffith M, Fewlass C, Watts M, Hessel C, Cordova J, et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine. 2005;23(13):1540–8.CrossRefPubMed

Loeb M, Russell ML, Moss L, Fonseca K, Fox J, Earn DJ, Aoki F, Horsman G, Van Caeseele P, Chokani K, et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA. 2010;303(10):943–50.CrossRefPubMed

Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med. 2001;344(12):889–96.CrossRefPubMed

Pebody R, Warburton F, Andrews N, Ellis J, von Wissmann B, Robertson C, Yonova I, Cottrell S, Gallagher N, Green H, et al. Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results. Euro Surveill. 2015;20(36):1–11.

Weycker D, Edelsberg J, Halloran ME, Longini Jr IM, Nizam A, Ciuryla V, Oster G. Population-wide benefits of routine vaccination of children against influenza. Vaccine. 2005;23(10):1284–93.CrossRefPubMed

Pradas-Velasco R, Antonanzas-Villar F, Martinez-Zarate MP. Dynamic modelling of infectious diseases: an application to the economic evaluation of influenza vaccination. PharmacoEconomics. 2008;26(1):45–56.CrossRefPubMed

Pitman RJ, White LJ, Sculpher M. Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales. Vaccine. 2012;30(6):1208–24.CrossRefPubMed

Jordan R, Connock M, Albon E, Fry-Smith A, Olowokure B, Hawker J, Burls A. Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence. Vaccine. 2006;24(8):1047–62.CrossRefPubMed

Vynnycky E, Pitman R, Siddiqui R, Gay N, Edmunds WJ. Estimating the impact of childhood influenza vaccination programmes in England and Wales. Vaccine. 2008;26(41):5321–30.CrossRefPubMed

10.

Pitman RJ, Nagy LD, Sculpher MJ. Cost-effectiveness of childhood influenza vaccination in England and Wales: results from a dynamic transmission model. Vaccine. 2013;31(6):927–42.

11.

Gerlier L, Lamotte M, Dos Santos MS, Damm O, Schwehm M, Eichner M. Estimates of the public health impact of a pediatric vaccination program using an intranasal tetravalent live-attenuated influenza vaccine in Belgium. Paediatr Drugs. 2016;18(4):303–18.CrossRefPubMed

12.

Rose MA, Damm O, Greiner W, Knuf M, Wutzler P, Liese JG, Kruger H, Wahn U, Schaberg T, Schwehm M, et al. The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study. BMC Infect Dis. 2014;14:40.CrossRefPubMedPubMedCentral

13.

Eichner M, Schwehm M, Hain J, Uphoff H, Salzberger B, Knuf M, Schmidt-Ott R. 4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany. BMC Infect Dis. 2014;14:365.CrossRefPubMedPubMedCentral

14.

Robert Koch Institute: Bericht zur Epidemiologie der Influenza in Deutschland Saison 2015/16. In. Berlin; 2016. https://influenza.rki.de/Saisonberichte/2015.pdf. Accessed 21 Apr 2017.

15.

Damm O, Eichner M, Rose MA, Knuf M, Wutzler P, Liese JG, Kruger H, Greiner W. Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany. Eur J Health Econ. 2015;16(5):471–88.CrossRefPubMed

16.

Statistisches Bundesamt: Bevölkerung Deutschlands bis 2060. 12. koordinierte Bevölkerungsvorausberechnung. In.; 2009.

17.

Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008;5(3):e74.CrossRefPubMedPubMedCentral

18.

Schröder-Bernhardi D, Grunow SS, Bauman U, Zöllner Y: Schutzimpfungen gegen Influenza werden bei Kindern und Jugendlichen äußerst selten durchgeführt – Ergebnisse einer Datenbankanalyse. In: 9 Jahrestagung der Deutschen Gesellschaft für Epidemiologie. Ulm; 2014.

19.

Bodeker B, Remschmidt C, Muters S, Wichmann O. Influenza, tetanus, and pertussis vaccination coverage among adults in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015;58(2):174–81.CrossRefPubMed

20.

Reuss AM, Walter D, Feig M, Kappelmayer L, Buchholz U, Eckmanns T, Poggensee G. Influenza vaccination coverage in the 2004/05, 2005/06, and 2006/07 seasons: a secondary data analysis based on billing data of the German associations of statutory health insurance physicians. Dtsch Arztebl Int. 2010;107(48):845–50.PubMedPubMedCentral

21.

Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 2008;2:CD004879.

22.

Jefferson T, Di Pietrantonj C, Rivetti A, Bawazeer GA, Al-Ansary LA, Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2014;7:CD001269.

23.

Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2010;2:CD004876.

24.

Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V, Ferroni E. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 2012;8:CD004879.

25.

Rhorer J, Ambrose CS, Dickinson S, Hamilton H, Oleka NA, Malinoski FJ, Wittes J. Efficacy of live attenuated influenza vaccine in children: a meta-analysis of nine randomized clinical trials. Vaccine. 2009;27(7):1101–10.CrossRefPubMed

26.

Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron AJ. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167(7):775–85.CrossRefPubMed

27.

Mossong J, Muller CP. Estimation of the basic reproduction number of measles during an outbreak in a partially vaccinated population. Epidemiol Infect. 2000;124(2):273–8.CrossRefPubMedPubMedCentral

28.

Moss WJ, Griffin DE. Global measles elimination. Nat Rev Microbiol. 2006;4(12):900–8.CrossRefPubMed

29.

Chowell G, Miller MA, Viboud C. Seasonal influenza in the United States, France, and Australia: transmission and prospects for control. Epidemiol Infect. 2008;136(6):852–64.CrossRefPubMed

30.

Williams CJ, Schweiger B, Diner G, Gerlach F, Haaman F, Krause G, Nienhaus A, Buchholz U: Seasonal influenza risk in hospital healthcare workers is more strongly associated with household than occupational exposures: results from a prospective cohort study in Berlin, Germany, 2006/07. BMC Infect Dis. 2010;10:8.

31.

Pebody RG, Green HK, Andrews N, Boddington NL, Zhao H, Yonova I, Ellis J, Steinberger S, Donati M, Elliot AJ, et al. Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza a and B strains, England, 2014/15. Euro Surveill. 2015;20(39):1–11.

32.

Blank PR, Schwenkglenks M, Szucs TD. Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons. Infection. 2009;37(5):390–400.CrossRefPubMed

33.

Meier CR, Napalkov PN, Wegmuller Y, Jefferson T, Jick H. Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis. 2000;19(11):834–42.CrossRefPubMed

34.

Sessa A, Costa B, Bamfi F, Bettoncelli G, D'Ambrosio G. The incidence, natural history and associated outcomes of influenza-like illness and clinical influenza in Italy. Fam Pract. 2001;18(6):629–34.CrossRefPubMed

35.

Heikkinen T, Silvennoinen H, Peltola V, Ziegler T, Vainionpaa R, Vuorinen T, Kainulainen L, Puhakka T, Jartti T, Toikka P, et al. Burden of influenza in children in the community. J Infect Dis. 2004;190(8):1369–73.CrossRefPubMed

36.

von Baum H, Schweiger B, Welte T, Marre R, Suttorp N, Pletz MW, Ewig S. How deadly is seasonal influenza-associated pneumonia? The German competence network for community-acquired pneumonia. Eur Respir J. 2011;37(5):1151–7.CrossRef

37.

Ewig S, Birkner N, Strauss R, Schaefer E, Pauletzki J, Bischoff H, Schraeder P, Welte T, Hoeffken G. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax. 2009;64(12):1062–9.CrossRefPubMedPubMedCentral

Title: Direct and indirect effects of influenza vaccination
Authors: Martin Eichner
Markus Schwehm
Linda Eichner
Laetitia Gerlier
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI: https://doi.org/10.1186/s12879-017-2399-4

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Direct and indirect effects of influenza vaccination

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2017

Community-based surveillance of norovirus disease: a systematic review

Provider initiated tuberculosis case finding in outpatient departments of health care facilities in Ghana: yield by screening strategy and target group

Using electronic health records and Internet search information for accurate influenza forecasting

Measuring (1,3)-β-D-glucan in tracheal aspirate, bronchoalveolar lavage fluid, and serum for detection of suspected Candida pneumonia in immunocompromised and critically ill patients: a prospective observational study

Tertiary syphilis in the lumbar spine: a case report

Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon: a cross-sectional study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page